Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03588780
Other study ID # 7167
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 6, 2018
Est. completion date October 2018

Study information

Verified date July 2018
Source University Hospital, Strasbourg, France
Contact Rémy BEAUJEUX, MD, PhD
Phone 33 3 88 12 78 71
Email remy.beaujeux@chru-strasbourg.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim is to describe the rate of delayed stent thrombosis after endovascular management of consecutive tandem lesions, in a patient series with systematic follow-up of stent patency. In addition, Investigatros aim to research baseline patient characteristics that are associated with a higher risk of delayed stent thrombosis and to evaluate the clinical consequences of stent thrombosis


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date October 2018
Est. primary completion date October 2018
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients who underwent endovascular treatments for acute ischemic stroke in Strasbourg University Hospitals between 01/01/2009 and 01/04/2018

- Association of extracranial internal carotid artery (ICA) occlusion or stenosis =70% using NASCET criteria and an intracranial arterial occlusion in the anterior circulation

Exclusion Criteria:

- Endovascular treatments for complication of surgical carotid endarterectomy

Study Design


Related Conditions & MeSH terms

  • Acute Stroke With Large Vessel Occlusion
  • Stroke

Locations

Country Name City State
France Service de Neuroradiologie Interventionnelle Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stent thrombosis rate participants will be followed for the duration of hospital stay, an expected average 15 days